NexMed, Inc.

NexMed, USA is a wholly owned subsidiary of Apricus Biosciences (NASDAQ:APRI).

The Company has a proprietary drug delivery technology, NexACT, which has been used to develop an impressive drug product pipeline, ranging from the pre-clinical stage to the NDA stage.